The Patent Finder
US

Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof

US 10,016,406 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Sep 14, 2022 (Vickers Venture Fund VI Pte. Ltd.).

Lapsed Jul 10, 2026 on the fee record · Medium confidence

Why Medium: The fee record shows no payment for this window, and USPTO's status still reads "Patented Case".

Second maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.

Filed Aug 18, 2017 as application 15/681,035 · Granted Jul 10, 2018
Base term, 20 years from filing
Today
Lapsed Jul 10, 2026
2010 2030
Clock starts
Aug 9, 2010
No longer in force
Jul 10, 2026
Granted
Jul 10, 2018
Term would have run to
Aug 9, 2030
base term after the term ends fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Aug 9, 2030: its 20-year base term, with no adjustment for prosecution delay. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 9, 2010, when application 12/852,706, the earliest non-provisional in its chain, was filed (this one was filed Aug 18, 2017)Aug 9, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee eventsThe fee record shows no payment for this window, and USPTO's status still reads "Patented Case"lapsed Jul 10, 2026Medium confidence
Computed term endThe steps above, in orderJul 10, 2026Medium confidence

This family

US 8,252,812In force
Aug 2030
Aug 2030
US 8,822,478In force
Sep 2030
Sep 2030
US 8,604,052Lapsed on the fee record
Dec 2025
Dec 2025
US 8,703,794In force
Aug 2030
Aug 2030
US 9,090,613In force
Aug 2030
Aug 2030
US 9,381,192In force
Aug 2030
Aug 2030
US 9,763,927In force
Aug 2030
Aug 2030
US 10,016,406this patent
Jul 2026
Jul 2026
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 26, 2018
Reel 45038, frame 585
Hood, John; Wallace, David Mark; Kc, Sunil KumarSamumed, LLCAssignment of Assignor's Interest
Mar 23, 2021
Reel 55693, frame 809
Samumed, LLCBiosplice Therapeutics, Inc.Assignment of Assignor's Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI (Plan) Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers-Splice Co.-Investment LLCSecurity Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Med-Pathways II LimitedSecurity Interest
Sep 14, 2022
Reel 61433, frame 786
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II LimitedSecurity Interest
Mar 12, 2026
Reel 75109, frame 434
TMF Group New York, LLC, Not Individually But Solely as Collateral AgentBiosplice Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited